Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
174.85
158.15
196.34
229.83
269.96
85.82
108.77
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
174.85
158.15
196.34
229.83
269.96
85.82
108.77
Raw Material Cost
14.95
13.29
17.30
19.81
18.89
11.13
11.14
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
59.13
53.04
53.62
47.51
47.37
42.21
45.06
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
2.47
2.42
2.38
3.37
3.12
3.89
4.14
Selling and Distribution Expenses
44.68
40.43
42.01
38.14
34.22
36.33
37.31
Other Expenses
3.81
4.15
2.54
1.94
-0.03
0.01
1.99
Total Expenditure (Excl Depreciation)
159.33
150.72
140.69
128.25
103.28
93.69
117.57
Operating Profit (PBDIT) excl Other Income
15.5
7.4
55.599999999999994
101.6
166.70000000000002
-7.9
-8.8
Other Income
11.67
3.87
5.70
7.85
-6.11
0.69
1.75
Operating Profit (PBDIT)
21.01
4.28
53.91
103.90
156.58
-11.62
-9.55
Interest
2.47
2.42
2.38
3.37
3.12
3.89
4.14
Exceptional Items
0.22
0.27
-1.85
0.18
-0.64
-0.09
0.08
Gross Profit (PBDT)
159.90
144.86
179.04
210.02
251.07
74.69
97.63
Depreciation
6.77
5.76
5.90
5.58
7.21
6.05
6.38
Profit Before Tax
11.98
-3.62
43.79
95.13
145.61
-21.65
-19.99
Tax
-14.14
-4.76
-5.57
2.27
8.34
-12.47
-2.88
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
26.12
1.14
49.36
92.86
137.26
-9.16
-17.09
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
-0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
26.12
1.14
49.36
92.86
137.26
-9.16
-17.09
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
-0.02
-0.02
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
26.12
1.14
49.36
92.86
137.26
-9.18
-17.10
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.6
0.6
0.6
0.6
0.6
0.05
0.0
Reserves
208.36
193.44
222.96
177.92
102.72
11.37
21.37
Earnings per share (EPS)
1.49
0.06
2.73
5.13
7.49
-0.44
-0.82
Diluted Earnings per share
1.49
0.06
2.73
5.13
7.49
-0.44
-0.82
Operating Profit Margin (Excl OI)
1.47%
-3.38%
21.55%
39.36%
57.59%
-21.39%
-16.25%
Gross Profit Margin
10.73%
1.35%
25.31%
43.82%
56.61%
-18.18%
-12.51%
PAT Margin
14.94%
0.72%
25.14%
40.4%
50.85%
-10.68%
-15.71%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 10.56% vs -19.41% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 2,272.73% vs -97.77% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 2,225.00% vs -99.17% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is 4.17% vs 0.00% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of Pharma Mar SA With
Figures in Million
Consolidate Annual Results
Change(EUR)
Change(%)
Net Sales
174.85
49.42
125.43
253.80%
Other Operating Income
0.00
0.00
0.00
Total Operating income
174.85
49.42
125.43
253.80%
Raw Material Cost
14.95
25.72
-10.77
-41.87%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
59.13
9.81
49.32
502.75%
Power Cost
0
0
0.00
Manufacturing Expenses
2.47
0.14
2.33
1,664.29%
Selling and Distribution Expenses
44.68
10.39
34.29
330.03%
Other Expenses
3.81
-0.99
4.80
484.85%
Total Expenditure (Excl Depreciation)
159.33
36.14
123.19
340.87%
Operating Profit (PBDIT) excl Other Income
15.53
13.29
2.24
16.85%
Other Income
11.67
-0.26
11.93
4,588.46%
Operating Profit (PBDIT)
21.01
15.16
5.85
38.59%
Interest
2.47
0.14
2.33
1,664.29%
Exceptional Items
0.22
0.00
0.22
Gross Profit (PBDT)
159.90
23.71
136.19
574.40%
Depreciation
6.77
1.95
4.82
247.18%
Profit Before Tax
11.98
13.07
-1.09
-8.34%
Tax
-14.14
3.68
-17.82
-484.24%
Provisions and contingencies
0
0
0.00
Profit After Tax
26.12
9.86
16.26
164.91%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
26.12
9.86
16.26
164.91%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
26.12
9.86
16.26
164.91%
Equity Capital
0
0
0.00
Face Value
0.60
0.05
0.00
Reserves
208.36
31.68
176.68
557.70%
Earnings per share (EPS)
1.49
0.16
1.33
831.25%
Diluted Earnings per share
1.49
0.16
1.33
831.25%
Operating Profit Margin (Excl OI)
1.47%
27.25%
0.00
-25.78%
Gross Profit Margin
10.73%
30.39%
0.00
-19.66%
PAT Margin
14.94%
19.96%
0.00
-5.02%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 17.49 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 10.56% vs -19.41% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 2.61 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 2,272.73% vs -97.77% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 0.93 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 2,225.00% vs -99.17% in Dec 2023
Annual - Interest
Interest 0.25 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 4.17% vs 0.00% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 1.47%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023






